Loading
Loading…
Loading…
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
29 Aug 2026, 11:00 am6d left
ECHS IFA RE 06 MED
9508649
GEM/2026/B/7700325
Two Packet Bid
Tab Levosulpiride 25 mg,Losartan 50 mg Tab,Rabeprazole Plus Domperidone 10 mg Tab,Clonazepam 0 poin
Ranchi, Jharkhand
Item wise evaluation
BOQ
8 documents required · 8 mandatory
3 yrs
₹15 L
₹90 L
80%
OIC PROCUREMENT, Military Hospital Namkum, Department of Military Affairs, Indian Army, Ministry of Defence, (Dinesh Kumar Kalra)
Exempted
Yes
19 Aug 2026
19 Aug 2026
29 Aug 2026
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | Tab Levosulpiride 25 mg | 1,700 | No | OICMSPC@2023 | 21 |
| 2 | Losartan 50 mg Tab | 87,000 | No | OICMSPC@2023 | 21 |
| 3 | Rabeprazole Plus Domperidone 10 mg Tab | 27,500 | No | OICMSPC@2023 | 21 |
| 4 | Clonazepam 0 point 5 mg Tab | 6,200 | No | OICMSPC@2023 | 21 |
| 5 | Piracetam 400 mg Tab | 10,000 | No | OICMSPC@2023 | 21 |
| 6 | Baclofen 10 mg Tab | 2,300 | No | OICMSPC@2023 | 21 |
| 7 | Torsemide 5mg Tab | 10,200 | No | OICMSPC@2023 | 21 |
| 8 | Atenolol 50 mg Tab | 44,500 | No | OICMSPC@2023 | 21 |
| 9 | Enalapril Maleate 10 mg Tab | 8,400 | No | OICMSPC@2023 | 21 |
| 10 | Cefuroxime 500 mg Tab | 8,600 | No | OICMSPC@2023 | 21 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_9508649.pdf
GEM_BID • 0.23 MB
re_6_2026-06-23-13-50-41_0fec8b4a16f8695dd5863b934ad834fa.pdf
BOQ • 0.07 MB
boq_item_sample_file_-7_2026-06-23-13-50-41_236a8c0f5c7241b3688684c7de1c3813.csv
BOQ • 0.00 MB
GEM_OTHER • 0.02 MB
gtc.pdf
GEM_OTHER • 0.71 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at [email protected].